Applied Biologics Published Ligament Regeneration Study

The study demonstrated collagen restoration in a preclinical model using a novel biologic treatment.

Updated on Sept. 30, 2026 in Life Sciences

Isometric editorial illustration featuring an abstract pattern of orderly cylindrical fibers representing collagen structure. — Scottsdale-based Applied Biologics has released a new study demonstrating successful collagen restoration in preclinical ligament injury models using a proprietary amniotic treatment. AI Illustration. Upload story photo >

Live Poll

Do you believe regenerative tissue research will significantly improve standard surgical outcomes in the future?

Scottsdale-based Applied Biologics has released research detailing a new method for ligament regeneration. The study shows significant collagen fibril recovery in preclinical models.

Why it matters

This research aims to determine whether biologic augmentation can drive the regeneration of native-like tissue instead of traditional scar-mediated repair.

The study utilized transmission electron microscopy at 25,000x magnification to characterize tissue. Treated ligaments reached a 90% recovery level of native fibril diameter within six weeks.

The players

Applied Biologics

This Scottsdale-based biotechnology company focuses on the development of regenerative medical therapies.

The details

Researchers treated a rabbit medial collateral ligament gap-defect model using a combination of XWRAP human amniotic membrane and an amniotic-fluid-derived biologic. The team utilized transmission electron microscopy to confirm the restoration of collagen fibril architecture.

Applied Biologics published the study results on September 30, 2026.
Treated ligament reached 75 nanometer mean fibril diameter at two weeks.
Mean fibril diameter reached 90% of native tissue by six weeks.

The Big Picture

This study follows the path of the ongoing development of amniotic-derived tissue scaffolds by demonstrating a new application for ligament repair. It highlights a shift in regenerative medicine toward promoting native tissue regeneration rather than scar formation.

This research could eventually lead to advanced surgical interventions that improve recovery times for sports medicine patients. These findings support potential future applications for XWRAP in clinical and orthopedic procedures.

The takeaway

The research provides a foundation for moving beyond scar-based repair in orthopedic surgery. Future developments may shift how medical professionals approach the healing of ligament injuries.